学术探索
学术期刊
新闻热点
数据分析
智能评审

Biomarkers in heart failure

被引：951
作者：
Braunwald, Eugene
机构：
[1] Brigham & Womens Hosp, TIMI Study Grp, Div Cardiovasc, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2008年 / 358卷 / 20期
关键词：
D O I：
10.1056/NEJMra0800239
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Heart failure results not only from cardiac overload or injury but also from a complex interplay among genetic, neurohormonal, inflammatory, and biochemical changes acting on cardiac myocytes, the cardiac interstitium, or both. This review focuses on biomarkers for heart failure other than routinely determined laboratory values and discusses how these might be used in assessing and managing heart failure. Copyright © 2008 Massachusetts Medical Society. All rights reserved.
引用
收藏
页码：2148 / 2159
页数：12
相关论文
共 88 条
  • [1] Executive summary:: HFSA 2006 comprehensive heart failure practice guideline
    Adams, KF
    Lindenfeld, J
    Arnold, JMO
    Baker, DW
    Barnard, DH
    Baughman, KL
    Boehmer, JP
    Deedwania, P
    Dunbar, SB
    Elkayam, U
    Gheorghiade, M
    Howlett, JG
    Konstam, MA
    Kronenberg, MW
    Massie, BM
    Mehra, MR
    Miller, AB
    Moser, DK
    Patterson, JH
    Rodeheffer, RJ
    Sackner-Bernstein, J
    Silver, MA
    Starling, RC
    Stevenson, LW
    Wagoner, LE
    Francis, GS
    Bristow, MR
    Cohn, JN
    Colucci, WS
    Greenberg, BH
    Force, T
    Krumholz, HM
    Liu, PP
    Mann, DL
    Piña, IL
    Pressler, SJ
    Sabbah, HN
    Yancy, CW
    [J]. JOURNAL OF CARDIAC FAILURE, 2006, 12 (01) : 10 - 38
  • [2] C-reactive protein in heart failure - Prognostic value and the effect of valsartan
    Anand, IS
    Latini, R
    Florea, VG
    Kuskowski, MA
    Rector, T
    Masson, S
    Signorini, S
    Mocarelli, P
    Hester, A
    Glazer, R
    Cohn, JN
    [J]. CIRCULATION, 2005, 112 (10) : 1428 - 1434
  • [3] Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
    Anand, IS
    Fisher, LD
    Chiang, YT
    Latini, R
    Masson, S
    Maggioni, AP
    Glazer, RD
    Tognoni, G
    Cohn, JN
    [J]. CIRCULATION, 2003, 107 (09) : 1278 - 1283
  • [4] Inflammatory mediators in chronic heart failure: An overview
    Anker, SD
    von Haehling, S
    [J]. HEART, 2004, 90 (04) : 464 - 470
  • [5] Uric acid and survival in chronic heart failure - Validation and application in metabolic, functional, and Hemodynamic staging
    Anker, SD
    Doehner, W
    Rauchhaus, M
    Sharma, R
    Francis, D
    Knosalla, C
    Davos, CH
    Cicoira, M
    Shamim, W
    Kemp, M
    Segal, R
    Osterziel, KJ
    Leyva, F
    Hetzer, R
    Ponikowski, P
    Coats, AJS
    [J]. CIRCULATION, 2003, 107 (15) : 1991 - 1997
  • [6] [Anonymous], CIRCULATION
  • [7] Cardiovascular proteomics - Tools to develop novel biomarkers and potential applications
    Arab, Sara
    Gramolini, Anthony O.
    Ping, Peipei
    Kislinger, Thomas
    Stanley, Brian
    van Eyk, Jennifer
    Ouzounian, Maral
    MacLennan, David H.
    Emili, Andrew
    Liu, Peter P.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (09) : 1733 - 1741
  • [8] Xanthine oxicloreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications
    Berry, CE
    Hare, JM
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2004, 555 (03): : 589 - 606
  • [9] ACUTE-PHASE RESPONSE OF HUMAN HEPATOCYTES - REGULATION OF ACUTE-PHASE PROTEIN-SYNTHESIS BY INTERLEUKIN-6
    CASTELL, JV
    GOMEZLECHON, MJ
    DAVID, M
    FABRA, R
    TRULLENQUE, R
    HEINRICH, PC
    [J]. HEPATOLOGY, 1990, 12 (05) : 1179 - 1186
  • [10] AUGMENTATION OF PLASMA NOR-EPINEPHRINE RESPONSE TO EXERCISE IN PATIENTS WITH CONGESTIVE HEART FAILURE
    CHIDSEY, CA
    BRAUNWALD, E
    HARRISON, DC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1962, 267 (13) : 650 - &
123456789